Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis (Q46202318)

20 December 2017

title

Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis (English)

1 reference

20 December 2017

0 references

4

Michael P Manns

1 reference

20 December 2017

author name string

Jan Freark de Boer

1

1 reference

20 December 2017

Matthias J Bahr

2

1 reference

20 December 2017

Klaus H W Böker

3

1 reference

20 December 2017

Uwe J F Tietge

5

1 reference

20 December 2017

publication date

12 December 2008

1 reference

20 December 2017

American Journal of Physiology - Gastrointestinal and Liver Physiology

published in

1 reference

20 December 2017

volume

296

1 reference

20 December 2017

page(s)

G196-201

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

Visfatin--a true or false trail to type 2 diabetes mellitus.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Diabetes and liver disease: an ominous association

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Glucose and insulin metabolism in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Hepatic glucose metabolism in humans--its role in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

21 January 2018

Assessing liver function

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

An update on visfatin/pre-B cell colony-enhancing factor, an ubiquitously expressed, illusive cytokine that is regulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Type 2 diabetes: principles of pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Altered alanine plasma levels despite normalized hepatic alanine extraction in the long-term course after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Alterations in glucose metabolism associated with liver cirrhosis persist in the clinically stable long-term course after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00029.2008

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00029.2008

1 reference

20 December 2017

PubMed ID

19074645

1 reference

20 December 2017